Edition:
United States

STAAR Surgical Co (STAA.OQ)

STAA.OQ on NASDAQ Stock Exchange Global Market

10.95USD
10:45am EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$10.95
Open
$10.90
Day's High
$11.10
Day's Low
$10.85
Volume
4,183
Avg. Vol
25,359
52-wk High
$12.30
52-wk Low
$7.40

Select another date:

Tue, Aug 15 2017

BRIEF-STAAR Surgical, Seoul/Busan BalGeunSeSang eye clinic announce strategic cooperation agreement

* STAAR Surgical and Seoul/Busan Balgeunsesang eye clinic announce strategic cooperation agreement

BRIEF-Staar Surgical Q2 loss per share $0.02

* Q2 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Staar Surgical to pay $7 million in investor suit over FDA violations

Staar Surgical Co, a manufacturer of implantable lenses to correct vision problems, has agreed to pay $7 million to resolve a lawsuit claiming the company misled investors about its compliance with Food and Drug Administration regulations.

BRIEF-Staar Surgical files for potential mixed shelf offering

* Staar Surgical Co files for potential mixed shelf offering of up to $200 million - SEC filing

BRIEF-STAAR Surgical announces CE Mark approval for the EVO+ visian ICL with aspheric (EDOF) optic

* STAAR Surgical announces CE Mark approval for the EVO+ Visian ICL with aspheric (EDOF) optic

BRIEF-Staar Surgical reports Q1 sales $20.4 million

* Q1 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S

BRIEF-Staar Surgical names Deborah Andrews interim CFO

* Steve Brown has resigned his position as chief financial officer effective April 28, 2017 Source text for Eikon: Further company coverage:

BRIEF-Stephen Brown notifies intention to resign as chief financial officer of STAAR Surgical

* Stephen Brown notified co of his intention to resign as vice president and chief financial officer

Select another date: